The Clotting Effects of Pentastarch and Normal Saline in Obstetric Patients
NCT00474162 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2008-02-21
Summary
Pregnant women are more likely to form clots than non-pregnant women as pregnancy increases the clotting factors present in the blood. This helps to prevent excess bleeding (hemorrhage) at the time of delivery. Hemorrhage occurs in 5-15% of pregnancies throughout the world, even when delivery is by cesarean section. When hemorrhage occurs the anesthesiologist will normally administer fluids into the woman's vein (intravenously) rapidly to replace the blood that the woman has lost. Two types of fluids are commonly used. One is a salt water solution (saline) and the other is a starch water solution (pentastarch). Use of either or both of these solutions is common during hemorrhage.
These same solutions (salt water solution and starch solution) are used at BC Women's Hospital during spinal anesthesia to prevent and treat low blood pressure (a common side effect of spinal anesthesia). This is standard practice whether you are in this study or not. You may also be given, depending on the anesthesiologist's preference, a drug (vasopressor) that causes the blood vessels to become narrow (constrict) to prevent or treat the low blood pressure. Whether you agree to be part of the study or not, your anesthesiologist will be watching your blood pressure closely throughout your operation and if your blood pressure becomes low he/she will treat it as is normally done.
Low blood pressure will also occur during hemorrhage. It is therefore important that we determine whether the starch solution, which is more effective than the salt solution in preventing low blood pressure during spinal anesthesia, does or does not affect clotting.
Research in non-pregnant adults (male and female) has found that laboratory tests of blood clotting change with these solutions. For saline the evidence in some studies suggests that the blood may clot better than normal while other studies suggest the opposite (does not clot as well). In pregnant and non-pregnant adults the blood does not clot as well with certain starch solutions. The starch solution used at BC Women's Hospital is called pentastarch and no research has looked at its effect on clotting in pregnant women. In non-pregnant adults pentastarch has less effect on clotting than other starch solutions.
The purpose of the study is to see how pentastarch (starch solution) and normal saline (water with salt in it) given at the time of spinal anesthesia for elective cesarean section affect the ability of pregnant woman's blood to clot.
Conditions
- Elective Cesarean Section
Interventions
- DRUG
-
Pentaspan®
15 ml/kg of starch solution, approximately 1 litre
- DRUG
-
Normal Saline
15 ml/kg of either saline solution, approximately 1 litre
Sponsors & Collaborators
-
Children's & Women's Health Centre of British Columbia
collaborator OTHER -
University of British Columbia
lead OTHER
Principal Investigators
-
Joanne Douglas, MD · University of British Columbia
-
Jason Ford, MD · University of British Columbia
-
Roanne Preston, MD · University of British Columbia
-
Rhona Siegmeth, MBChB, BSc, FRCA · University of British Columbia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2008-02-29
- Completion
- 2008-02-29
Countries
- Canada
Study Locations
More Related Trials
-
Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia
NCT04576663 ·Status: UNKNOWN ·Phase: NA
-
Dexamethasone for Post-operative Pain After Cesarean Delivery Under Neuraxial Anesthesia.
NCT07257406 ·Status: COMPLETED ·Phase: NA
-
Reducing Blood Loss During Cesarean Hysterectomy for Placenta Accreta Spectrum
NCT03570710 ·Status: COMPLETED ·Phase: NA
-
The Prophylactic Role of Tranexamic Acid in High Risk Pregnant Women Undergoing Elective Cesarean Section in Prevention of Postpartum Hemorrhage
NCT05434533 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-myometrial Vasopressin During Cesarean Section in Placenta Previa
NCT03725553 ·Status: COMPLETED ·Phase: NA
-
Antenatal Corticosteroid in Elective Cesarean Section
NCT03396107 ·Status: COMPLETED ·Phase: PHASE3
-
The Potency of Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension
NCT05035472 ·Status: UNKNOWN ·Phase: NA
-
Coagulation Factor Changes Associated With Postpartum Hysterectomies
NCT00456547 ·Status: COMPLETED
-
Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia
NCT05035498 ·Status: RECRUITING ·Phase: NA
-
Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section
NCT06010368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Prophylactic Methylergonovine for Twin Cesarean
NCT05772156 ·Status: COMPLETED ·Phase: PHASE4
-
Colloid Co-hydration and Vasoconstrictor Infusion for Prevention of Hypotension During Cesarean Section
NCT04404946 ·Status: COMPLETED ·Phase: NA
-
Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia
NCT02622126 ·Status: COMPLETED ·Phase: PHASE2
-
Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
NCT03852797 ·Status: COMPLETED ·Phase: NA
-
Maternal Haemodynamic Changes After Crystalloid Co-loading and Phenylephrine Versus Phenylephrine Alone During Spinal Anaesthesia for Elective Caesarean Delivery
NCT04026685 ·Status: COMPLETED ·Phase: NA
-
Carbetocin Versus Oxytocin and Hemodynamic Effects
NCT00977769 ·Status: COMPLETED ·Phase: PHASE4
-
Optimization of Hemodynamic Conditions During Caesarean Section Under Spinal Anaesthesia
NCT01278238 ·Status: COMPLETED ·Phase: NA
-
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
NCT04305756 ·Status: COMPLETED ·Phase: NA
-
Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.
NCT03778242 ·Status: COMPLETED ·Phase: NA
-
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia
NCT04556357 ·Status: COMPLETED ·Phase: NA
-
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.
NCT04556370 ·Status: COMPLETED ·Phase: NA
-
Intravenous Lidocaine and Quality of Recovery After Cesarean Delivery
NCT02257346 ·Status: WITHDRAWN ·Phase: NA
-
Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery
NCT03741075 ·Status: UNKNOWN ·Phase: NA
-
Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section
NCT00379691 ·Status: COMPLETED ·Phase: NA
-
Fibrinogen Concentrate and Placenta Acreta Spectrum
NCT05938062 ·Status: COMPLETED ·Phase: NA